MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, R. R.
Right arrow Articles by Strader, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, R. R.
Right arrow Articles by Strader, C. D.

Identification of allosteric antagonists of receptor-guanine nucleotide- binding protein interactions

RR Huang, RN Dehaven, AH Cheung, RE Diehl, RA Dixon and CD Strader

Department of Molecular Pharmacology and Biochemistry, Merck, Sharp, and Dohme Research Laboratories, Rahway, New Jersey 07065.

A series of compounds that inhibit the coupling of the alpha 2- adrenergic receptor and the beta 2-adrenergic receptor to the guanine nucleotide-binding proteins (G proteins) Gi and Gs, respectively, have been identified. This inhibition of G protein coupling was detected by the ability of the compounds to reduce the affinity of these receptors for agonists without affecting antagonist affinity. Analysis of the structure-activity relationships of these compounds revealed a requirement for regularly spaced anionic substituents on amphipathic structures for this inhibition to occur. The compounds do not interact at the ligand binding site of the receptor or at the GTP binding site of the G protein. The identification of compounds that can uncouple receptors from G proteins demonstrates the potential for the discovery of small molecule inhibitors of receptor-G protein interactions that act as allosteric antagonists at this site.

Volume 37, Issue 2, pp. 304-310, 02/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
W.-C. Chung and J. C. Kermode
Suramin Disrupts Receptor-G Protein Coupling by Blocking Association of G Protein {alpha} and {beta}{gamma} Subunits
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 191 - 198.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Molinari, C. Ambrosio, D. Riitano, M. Sbraccia, M. C. Gro, and T. Costa
Promiscuous Coupling at Receptor-Galpha Fusion Proteins. THE RECEPTOR OF ONE COVALENT COMPLEX INTERACTS WITH THE alpha -SUBUNIT OF ANOTHER
J. Biol. Chem., April 25, 2003; 278(18): 15778 - 15788.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Christopoulos and T. Kenakin
G Protein-Coupled Receptor Allosterism and Complexing
Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Benaud, M. Oberst, J. P. Hobson, S. Spiegel, R. B. Dickson, and C.-Y. Lin
Sphingosine 1-Phosphate, Present in Serum-derived Lipoproteins, Activates Matriptase
J. Biol. Chem., March 15, 2002; 277(12): 10539 - 10546.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. B. Fawzi, D. Macdonald, L. L. Benbow, A. Smith-Torhan, H. Zhang, B. C. Weig, G. Ho, D. Tulshian, M. E. Linder, and M. P. Graziano
SCH-202676: An Allosteric Modulator of Both Agonist and Antagonist Binding to G Protein-Coupled Receptors
Mol. Pharmacol., January 1, 2001; 59(1): 30 - 37.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Waldhoer, E. Bofill-Cardona, G. Milligan, M. Freissmuth, and C. Nanoff
Differential Uncoupling of A1 Adenosine and D2 Dopamine Receptors by Suramin and Didemethylated Suramin (NF037)
Mol. Pharmacol., May 1, 1998; 53(5): 808 - 818.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. B. Thompson, S. M. Wade, J. K. Harrison, M. N. Salafranca, and R. R. Neubig
Cotransfection of Second and Third Intracellular Loop Fragments Inhibit Angiotensin AT1a Receptor Activation of Phospholipase C in HEK-293 Cells
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 216 - 222.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Hohenegger, M. Waldhoer, W. Beindl, B. Boing, A. Kreimeyer, P. Nickel, C. Nanoff, and M. Freissmuth
Gsalpha-selective G protein antagonists.
PNAS, January 6, 1998; 95(1): 346 - 351.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. A. Thomas, M. J. Carson, M. J. Neal, and J. G. Sutcliffe
Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide
PNAS, December 9, 1997; 94(25): 14115 - 14119.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Fennewald and R. F. Rando
Inhibition of High Affinity Basic Fibroblast Growth Factor Binding by Oligonucleotides
J. Biol. Chem., September 15, 1995; 270(37): 21718 - 21721.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. L. Rymer and T. A. Good
The Role of G Protein Activation in the Toxicity of Amyloidogenic Abeta -(1-40), Abeta -(25-35), and Bovine Calcitonin
J. Biol. Chem., January 19, 2001; 276(4): 2523 - 2530.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics